Skip to main content

JHOP - August 2026 Vol 16, No 4

Original Research
Original Research
Online First
Original Research, Adverse Events, Biosimilars
Arthralgia Rates and Treatment Among Patients Receiving Bevacizumab-awwb Versus Bevacizumab
Rachel Schneider, PharmD; Justin Grahl, PharmD; Susan Duyar-Ayerdi, MD, MA; Ruta Brazauskas, PhD; Bethany Canales, MPH; Erin McGurty, PharmD, BCOP
Read More
Online First
Original Research, Lung Cancer, Immunotherapy, Adverse Events
Outcomes of Early Versus Delayed Initiation of Immunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Matthew Warrick, PharmD, BCPS, BCOP; Rebecca Worden, PharmD, BCOP; Carly Kesler, PharmD, BCOP; Katie Murto, PharmD, BCOP; Amanda Edwards, PharmD, BCOP, CPP
Read More
Online First
Original Research, Adverse Events, Pediatric Cancer, Acute Lymphoblastic Leukemia
Impact of Universal Pegaspargase Premedication on Substitution Rates and Adverse Events
Jordan Wallace, PharmD, BCOP; Taylor Dennison, PharmD, BCOP; Jess Auten, PharmD, BCOP; Carmen Echols, PharmD, BCPPS; Kynlon Phillips, PharmD, BCPS, BCOP; Jenna Bognaski Kaplan, PharmD, BCPPS
Read More